The Lundquist Institute Receives $1.75 Million Grant from Steven & Alexandra Cohen Foundation to Fund End-of-Life Therapies

The grant will fund clinical trials to study the efficacy of psilocybin in treating the emotional suffering associated with terminal medical illness

LOS ANGELES — The Lundquist Institute has received a $1.75 million grant from the Steven & Alexandra Cohen Foundation to fund a multi-site clinical trial to evaluate the efficacy and safety of the compound psilocybin in individuals with severe psychological distress associated with a terminal medical illness. The grant will also support education and outreach programs related to the use of psilocybin within the field of palliative care.

Amgen Sponsors Golden Ticket at Biolabs LA at The Lundquist Institute to Help Accelerate Life Science Startups

Amgen Golden Ticket Winners to Receive Lab Space, Mentoring and Other Benefits

THOUSAND OAKS, Calif. – Amgen (NASDAQ:AMGN) today announced a three-year, Golden Ticket sponsorship of the BioLabs LA at The Lundquist Institute (TLI) life sciences co-working space to accelerate the development of new therapies, medical devices, and diagnostics to advance and improve human health. The BioLabs at TLI shared laboratory space was created to help high-potential life science and biotech startups overcome key obstacles for many early stage organizations, including: access to laboratory infrastructure, programming, and business development mentorship.